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Sir,
The emergence of the mobilizable colistin resistance (mcr) genes
raises concerns for public health, as colistin is considered one of
the last-line therapeutics for treatment of infections with MDR bac-
teria, including carbapenem-resistant Enterobacteriaceae.1 Since
its first description from China in 2015, 10 mcr families have been
reported worldwide, identified in several bacterial species originat-
ing from various animal, human and environmental samples.2 The
event of co-occurrence of two mcr variants on the same plasmid is
uncommon.3 Here, we report a novel mcr variant, mcr-3.40, co-lo-
cated with mcr-2.3 and blaCTX-M-63 on an IncHI1B/IncFIB plasmid
found in Klebsiella pneumoniae.
Colistin-resistant K. pneumoniae strain 90CM2 was isolated
from a stool sample of a healthy farmer in North-Eastern Thailand
as a part of a cross-sectional study.4 The study was conducted
according to the Helsinki declaration and the protocol involving hu-
man participants was approved by the Khon Kaen University Ethics
Committe (Project ID: HE612268 and 0514.1.75/66, respectively).
Informed consent was obtained after the experimental proce-
dures had been completely explained. MIC determination using
the EUVSEC Plate (Trek diagnostics, Thermo Scientific, USA),
interpreted using EUCAST guidelines (www.eucast.org), showed
that strain 90CM2 was resistant to colistin (MIC .16 mg/L), third-
generation cephalosporins (MIC .8 mg/L for ceftazidime and MIC
.4 mg/L for cefotaxime) and other antimicrobial agents (Table S1,
available as Supplementary data at JAC Online).
Hybrid assembly was performed using Unicycler5 based on
short reads obtained using Illumina Novoseq 6000 (Novogene,
en.novogene.com) and long reads obtained using a MinION device
(Rapid Sequencing Kit SQK-RBK004 and Flow Cell R9.4; Oxford
Nanopore Technologies, UK). Annotation was performed using
Prokka v1.14.6 and the BLAST tool. Antibiotic resistance and viru-
lence genes were identified using the online CGE platform (http://
www.genomicepidemiology.org/) and the Kleborate tool,6
respectively. ISs were explored using ISfinder (https://isfinder.bio
toul.fr/).
WGS demonstrated that K. pneumoniae strain 90CM2
(BioProject no. PRJNA669428) belonged to ST17 with a chromo-
some size of 5 285 993 bp and five plasmids, of which four were
complete and circularized during assembly (Figure S1). Antibiotic
resistance and virulence determinants are listed in Table S2. Genes
encoding aerobactin and yersiniabactin were found, rendering this
strain a hypervirulent K. pneumoniae.7 Interestingly, plasmid
p90CM2-MCR (253 649 bp) harboured both mcr-2.3 and mcr-3-like
genes. The MCR-3 allele differed by one amino acid compared
with MCR-3 (Q486T, KY924928.1), MCR-3.11 (V373G, MG489958.1)
and MCR-3.24 (N468T, NG060580.1). The new allele variant was
designated as mcr-3.40 (MT872722) by NCBI. Additionally,
p90CM2-MCR also harboured several other antibiotic resistance
genes [blaCTX-M-63 (b-lactams), aphA-2 (aminoglycosides), strA and
strB (streptomycin), qnrS1 (quinolones), mph(A) (macrolides) and
bleO (bleomycin)]. Further investigation of the plasmid structure
revealed that p90CM2-MCR had an average GC content of 46.2%
and encoded 263 predicted ORFs, including three replicons
(IncHI1B-like, IncFIB-like and IncN). Furthermore, self-transferabil-
ity of p90CM2-MCR into Escherichia coli J53 (AziR) during liquid mat-
ing was confirmed by S1-PFGE (Figure S2). The average plasmid
transfer frequency was 1.12%10#3+5.7%10#4 transconjugants
per recipient (Supplementary Materials and methods).
Plasmid p90CM2-MCR exhibited a high backbone similarity
(.78% coverage and .98% identity) to plasmid pNDM-MAR, plas-
mid pENVA and plasmid pUNNAMED1, including IncHI1B/IncFIB
replicons, a plasmid transfer (tra and trh) locus, tellurium resis-
tance (ter) genes and a type IV CRISPR8 (Figure 1a). Thus, p90CM2-
MCR was considered a member of the novel IncH plasmid family,
sharing a common ancestry with compared plasmids (pNDM-MAR,
pENVA and pUNNAMED1). By contrast, p90CM2-MCR contained an
ISKpn25-like insertion (7.9 kb) and a unique MDR region (37 kb) not
identified on the reference plasmids. To the best of our knowledge,
an association between this plasmid type and mcr genes has never
been reported before.
Both mcr genes were embedded within an MDR region
surrounded by the remnants of Tn5393 (IRL-strAB and
Dtransposase-IRR) (Figure 1b). Each identified module of
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Figure 1. (a) Linear comparison of p90CM2 and three reference plasmids (pNDM-MAR, pENVA and pUNNAMED1). (b) Linear comparison of the MDR
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the MDR region demonstrated a high similarity to several differ-
ent plasmid segments. The two largest modules (module I
containing mcr-2.3 and module II containing mcr-3.40)
were highly similar (99%) to regions located on plasmid
pQnrB4_020042 (accession number CP028537) and plasmid
pT38_MCR3 (accession number MK770642), respectively.
Within module I, a putative composite transposon (5 kb) har-
bouring mcr-2.3 was flanked by duplicates of novel IS elements,
designated as ISKpn71 (IS256 family) by ISfinder. A pair of
direct repeats, ATTATTTTT, flanking the putative composite
transposon, indicated its previous insertion into this region and,
thus, possible mobilization. Additionally, the putative transpo-
son contained ISSpu2, located right upstream of mcr-2.3. To
the best of our knowledge, this is the first report of an mcr gene
associated with ISSup2.
Conversely, mcr-3.40 was detected in a known mcr-3 genetic
context, mcr-3.40-dgkA-ISKpn40, within a region flanked by
complete copies of IS4321. A similar segment was discovered
on plasmid pT38-MCR3 (Figure 1b, module II) within antibiotic
resistance island (‘ARI’)-A.9 Moreover, this region was bracketed
by three copies of IS26; one identified upstream and the other
two identified downstream from the IS4321-flanked region.
Due to the opposite directions of IS26,10 a segment encom-
passing modules I-II-III could potentially be moved by a new
composite transposon. However, it is inconclusive whether
the identified putative transposons were involved in the events
that tailored the highly mosaic structure of the MDR region of
p90CM2-MCR.
Self-transferability of p90CM2-MCR and possible mobilization of
individual MDR segments could ultimately pose a public health
threat. Moreover, coexistence of resistance and virulence plasmids
within a single K. pneumoniae clone recovered from an asymp-
tomatic carrier is also of concern.
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